Ron Christensen
Chief Medical Officer
Medical
MAPI Group
Italy
Biography
Ronald Christensen, M.D., contributes his thought leadership to the industry by participating in key working groups and workshops. His guidance and knowledge of key indications—including Cystic Fibrosis, Crohn’s Disease, and rare disease areas including Cushing’s syndrome and Duchenne’s Muscular—is a true asset in our experience. At Mapi, Dr. Christensen has continued his involvement as a thought leader. He was invited to present at the 5th Annual International Conference on Rare Diseases and Orphan Drugs (ICORD). In 2009, he was invited to join an NIH Working Group to develop a standardized Global Rare Disease Registry (GRDR). In 2016, Dr. Christensen was invited to serve as a member of the International Rare Diseases Research Consortium (IRDiRC) Task Force, a group working to achieve two main objectives by 2020: to deliver 200 new therapies for rare diseases, and the means to diagnose most rare diseases.
Research Interest
Diseases Research
